ELUCID Trademark

Trademark Overview

On Friday, March 17, 2023, a trademark application was filed for ELUCID with the United States Patent and Trademark Office. The USPTO has given the ELUCID trademark a serial number of 97843852. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, December 9, 2024. This trademark is owned by Elucid Bioimaging Inc.. The ELUCID trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing online, non-downloadable software for use with medical imaging tools for evaluating the amount and type of plaque in a patient's arteries and assessing the risks of same

General Information

Serial Number97843852
Word MarkELUCID
Filing DateFriday, March 17, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, December 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding online, non-downloadable software for use with medical imaging tools for evaluating the amount and type of plaque in a patient's arteries and assessing the risks of same

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, April 9, 2023
Primary Code042
First Use Anywhere DateFriday, August 23, 2013
First Use In Commerce DateFriday, August 23, 2013

Trademark Owner History

Party NameElucid Bioimaging Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events

Event DateEvent Description
Wednesday, April 26, 2023EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Tuesday, March 21, 2023NEW APPLICATION ENTERED
Sunday, April 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 19, 2023ASSIGNED TO EXAMINER
Wednesday, April 26, 2023COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Wednesday, April 26, 2023EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, April 26, 2023NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, July 18, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, July 18, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, October 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 23, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, October 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 23, 2023SUSPENSION LETTER WRITTEN
Monday, October 23, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, April 24, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, October 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 12, 2024ASSIGNED TO EXAMINER
Tuesday, October 22, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 29, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, December 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 9, 2024ASSIGNED TO LIE
Tuesday, October 22, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

elucid patient plaque type arteries assessing same risks amount evaluating downloadable